DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
206 hedge funds and large institutions have $1.54B invested in DIPLOMAT PHARMACY, INC. in 2018 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 70 reducing their positions, and 31 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 2 → 8 (+6)
36% more capital invested
Capital invested by funds: $1.14B → $1.54B (+$405M)
26% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 31
2% more funds holding
Funds holding: 201 → 206 (+5)
6% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 70
34% less call options, than puts
Call options by funds: $3.46M | Put options by funds: $5.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$53.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$39.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$29.5M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$28.7M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$46.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.9M |
| 3 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$14.4M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$12.2M |
| 5 |
JP Morgan Chase
New York
|
-$10.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JG
226
Jefferies Group
New York
| – | -$79.3K | -3,403 | Closed |
|
227
Parallax Volatility Advisers
San Francisco,
California
| – | -$44K | -2,191 | Closed |
|
|
IWM
228
IHT Wealth Management
Chicago,
Illinois
| – | -$39K | -1,987 | Closed |
|
229
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$30K | -1,500 | Closed |
|
|
IA
230
IFP Advisors
Tampa,
Florida
| – | -$25K | -1,231 | Closed |
|
|
CIP
231
Convergence Investment Partners
Palm Beach Gardens,
Florida
| – | -$11K | -550 | Closed |
|
|
HNB
232
Huntington National Bank
Columbus,
Ohio
| – | -$9K | -460 | Closed |
|
|
WA
233
WealthTrust-Arizona
Scottsdale,
Arizona
| – | -$3K | -171 | Closed |
|
|
APP
234
Avantax Planning Partners
Dubuque,
Iowa
| – | -$2K | -120 | Closed |
|
|
IIC
235
Integrated Investment Consultants
Bloomfield Hills,
Michigan
| – | -$2K | -100 | Closed |
|
|
SWP
236
Stratos Wealth Partners
Beachwood,
Ohio
| – | -$1K | -35 | Closed |
|
|
ADL
237
Asset Dedication LLC
San Francisco,
California
| – | +$70 | +3 | New |
|
DPLO Hedge Fund Activity: Q2 2018 in Review
206 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2018, worth a combined $1.54B — up 36% from $1.14B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new DPLO positions and 31 closed out — a net gain of 8 holders — while 74 added to existing stakes and 70 trimmed.
The largest buyer was Capital World Investors, adding an estimated $53.5M. The largest seller was Frontier Capital Management, cutting an estimated $46.6M.
- 206 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2018, up from 201 in Q1 2018.
- Funds reported $1.54B of DIPLOMAT PHARMACY, INC. stock for Q2 2018, up 36% quarter-over-quarter.
- 39 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2018 and 31 closed out, a net change of +8 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q2 2018 was Capital World Investors, an estimated $53.5M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q2 2018 was Frontier Capital Management, an estimated $46.6M sold.
Based on aggregated 13F filings for Q2 2018.